🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Karie Runcie

NewYork–Presbyterian Hospital

ORCID: 0000-0002-0598-7663

Also affiliated with Columbia University Irving Medical Center, New York Hospital Queens, Herbert Irving Comprehensive Cancer Center, Columbia University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Single-Cell RNAseq Analysis Reveals Robust, Anti-PD-1-Mediated Increase of Immune Infiltrate in Metastatic Castration-Sensitive Prostate Cancer”.

Single-Cell RNAseq Analysis Reveals Robust, Anti-PD-1-Mediated Increase of Immune Infiltrate in Metastatic Castration-Sensitive Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.06.490968
N/A
0DataRank · unranked
2 citations

Aleksandar Obradović, Matthew C. Dallos, Emerson A. Lim, Karie Runcie, Casey R. Ager +15 more

Gene modules in association with Kaiso and LC3 regulatory pathways to predict survival and response to therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e13573
N/A
0DataRank · unranked
0 citations

Nasreen A. Vohra, Anna María Nápoles, Eliseo Perez-Stables, Jung S. Byun, Stephen M. Hewitt +4 more

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer

Cancer Cell(2023)10.1016/j.ccell.2023.10.006
N/A
0DataRank · unranked
77 citations

Aleksandar Obradović, Matthew C. Dallos, Emerson A. Lim, Karie Runcie, Casey R. Ager +16 more

Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma

Current Opinion in Oncology(2023)10.1097/cco.0000000000000939
N/A
0DataRank · unranked
6 citations

Yuanquan Yang, Karie Runcie, Ramaprasad Srinivasan, Eric A. Singer, Taylor Goodstein

The PRIME-CUT study: A single-arm phase 2 study of ADT with PD-1 blockade and docetaxel in men with metastatic hormone-sensitive prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e17089
N/A
0DataRank · unranked
2 citations

Matthew C. Dallos, Emerson A. Lim, Karie Runcie, Jianhua Hu, Israel Lowy +3 more

Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma

Current Oncology Reports(2024)10.1007/s11912-024-01523-8
N/A
0DataRank · unranked
0 citations

Jennifer W. Li, Karie Runcie, Michael A. Liu

Impact of pre-existing diabetes mellitus on acute care use in older patients with metastatic prostate cancer on androgen receptor signaling inhibitors.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.119
N/A
0DataRank · unranked
0 citations

Rohit Raghunathan, Karie Runcie, Shikun Wang, Jason D Wright, Alexander Z. Wei +3 more

Association of polypharmacy with acute care utilization in older adults receiving androgen receptor signaling inhibitors for metastatic prostate cancer.

JCO Oncology Practice(2025)10.1200/op.2025.21.10_suppl.518
N/A
0DataRank · unranked
0 citations

Rohit Raghunathan, Margaux Wooster, Karie Runcie, Shikun Wang, Jason D Wright +4 more

Association between medication burden and acute care use in older metastatic prostate cancer patients on androgen receptor signaling inhibitors

Cancer(2025)10.1002/cncr.70163
N/A
0DataRank · unranked
0 citations

Rohit Raghunathan, Karie Runcie, Margaux Wooster, Shikun Wang, Jason D. Wright +4 more